Manufacturing / Pharmaceutical Preparations
SELLAS Life Sciences Group, Inc.
SLS
$11.65
+$0.38 (+3.38%)
Price as of Oct 9, 2026 19:29 UTC
2.9 B
Market Cap (Mid Cap)
33%
IV Rank
151.5%
Implied Volatility
Nov 10
Next Earnings
Technical Signals
as of Oct 7
Bearish
1 of 7
Trend
- Above 20-day average $11.87
- Above 50-day average $11.93
- Above 200-day average $8.09 · +39.7%
- Moving averages stacked Not aligned
Momentum
- Golden cross (50/200) —
- Momentum cross (20/50) Down · 1d ago
Volume
- Below-average volume 0.5x avg
Price & Trend
Daily candles with EMA 20, SMA 50. Drag to zoom.
Options Activity & Greeks
Implied volatility, flow, and dealer positioning from the options market.
Put/Call Ratio
0.22
Bullish skew
Implied Volatility
151.5%
1% percentile
IV vs Realized
Options rich
30d HV 79.1%
Options Heat Map
Delta-risk grid for SLS options across strikes and expirations. Hover any cell for full Greeks.
Loading option chain data...
Insider Trades
4 buys
0 sells
| Date | Insider | Title | Type | Shares | Value | Since Trade |
|---|---|---|---|---|---|---|
| Jun 16, 2026 | Stergiou Angelos M. | Grant | 1,065,000 | $0 | +49.5% | |
| Jan 07, 2026 | SCHEINBERG DAVID A | Grant | 50,000 | $0 | +178.7% | |
| Jan 07, 2026 | Kalin Katherine Bach | Grant | 50,000 | $0 | +178.7% | |
| Jan 07, 2026 | CICIC DRAGAN | Grant | 300,000 | $0 | +178.7% | |
| Jan 07, 2026 | VAN NOSTRAND ROBERT L | Grant | 50,000 | $0 | +178.7% | |
| Jan 07, 2026 | Burns John Thomas | Grant | 300,000 | $0 | +178.7% | |
| Jan 07, 2026 | Varian John | Grant | 50,000 | $0 | +178.7% | |
| Jan 07, 2026 | Wasman Jane | Grant | 50,000 | $0 | +178.7% | |
| Jan 07, 2026 | Varian John | Other | 50,000 | $0 | +178.7% | |
| Jan 07, 2026 | Burns John Thomas | Other | 300,000 | $0 | +178.7% |
Earnings History
| Date | Quarter | EPS Est. | EPS Actual | Surprise | Result |
|---|---|---|---|---|---|
| Aug 10, 2026 | Q2 2026 | -$0.05 | |||
| Mar 31, 2026 | Q1 2026 | -$0.04 | -$0.05 | -23.8% | Miss |
| Dec 31, 2025 | Q4 2025 | -$0.07 | -$0.05 | +23.9% | Beat |
| Sep 30, 2025 | Q3 2025 | -$0.07 | -$0.06 | +10.0% | Beat |
| Jun 30, 2025 | Q2 2025 | -$0.08 | -$0.07 | +15.9% | Beat |
| Mar 31, 2025 | Q1 2025 | -$0.11 | -$0.07 | +34.0% | Beat |
Track SLS with ThetaPal
Get insider trade alerts, AI portfolio analysis, and options roll recommendations for SLS and your entire portfolio.